Role of circulating dipeptidyl peptidase 4 in insulin resistance and cardiovascular disease

循环二肽基肽酶 4 在胰岛素抵抗和心血管疾病中的作用

• 批准号: 397286
• 负责人: Vulesevic Branka
• 金额: $ 6.56万
• 依托单位: University of Ottawa Heart Institute
• 依托单位国家: 加拿大
• 项目类别: Fellowship Programs
• 财政年份: 2018
• 资助国家: 加拿大
• 起止时间: 2018-11-01 至 2020-11-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=397286&lang=en
• 关键词: Dipeptidyl Peptidase 4; Heart Failure; Inflammation; Liver; Metabolic Syndrom

Patients with Diabetes have an increased risk of heart disease compared with patients who do not. It is also known that when patients have diabetes, communication between the liver, pancreas, immune system and cardiovascular system becomes disturbed. The

糖尿病患者与非糖尿病患者相比，患心脏病的风险更高。此外，糖尿病患者的肝脏、胰腺、免疫系统、心血管系统之间的交流也会受到干扰。的